The eDrugSearch Blog » Schering-Plough

Merck and Schering-Plough: partners in slime

Cary Byrd — Wed, 23 Jan 2008 14:14:16 +0000

Oh what fun it is to cover Big Pharma. First we get the Wall Street Journal crediting Peter Rost and BrandweekNRX for breaking an insider trading scandal at Schering-Plough.

Then we get Merck and Schering-Plough pulling their popular “two sources of cholesterol” commercials from television because Vytorin apparently does not reduce the buildup of fatty plaque as claimed.

As Media Orchard puts it, there are

Two Ways to Get Egg on Your Face

1. You can crack one open.
2. You can be Merck CEO Richard Clark.

Will Big Pharma and the FDA really take care of you?

Cary Byrd — Tue, 06 Feb 2007 20:27:07 +0000

This documentary trailer specifically references the Vioxx scandal — but it serves as a general reminder of the toxic relationship between the FDA and Big Pharma. Check it out:

Schering-Plough says it operates with integrity — now, anyway

Cary Byrd — Mon, 11 Dec 2006 01:01:03 +0000

From the Dallas Business Journal:

Texas will receive more than $15.7 million under a national settlement with pharmaceutical company Schering-Plough Corp., Texas Attorney General Greg Abbott said Thursday. Texas and all other states accused Kenilworth, N.J.-based Schering-Plough (NYSE:SGP) of failing to provide the Medicaid program with the lowest drug prices…

Brent Saunders, senior vice president for the company’s global compliance and business practices, said that since April 2003 when new management joined Schering-Plough and launched an action agenda, the company has made great strides in building a company that centers around business integrity.

“New management” for Big Pharma is the equivalent of putting a new sheepskin on the wolf. It will carry Schering-Plough until its next scandal, when “new management” will come to the PR rescue again.